REDCap alternatives for teams that need more than a survey tool
If you've outgrown REDCap, you're in the right place. WeGuide gives research teams whitelabel participant apps, regulatory grade eConsent, validated eCOA, and native wearable data, on a managed platform your IT team doesn't have to run. It connects to your existing REDCap instance if you're not ready to move off it.
No pressure, no hard sell. A 30 minute walkthrough with a research colleague who's built platforms like yours.
.png)
Used by leading research and medical institutes.








%201.avif)










REDCap does one thing very well: it lets academic research teams capture structured data through forms and surveys without involving a software vendor. For observational data collection at a single academic site, it's hard to beat.
The pressure starts when studies get more ambitious. When a protocol needs validated eCOA instruments, push notification reminders, Apple Watch or Garmin data, regulatory grade eConsent, or a whitelabel mobile app that participants will actually open, REDCap's original scope doesn't stretch to fit. Teams end up duct taping REDCap to a mobile app vendor, an eConsent tool, and a wearable SDK, and then asking their IT department to hold the whole thing together on a self hosted server.
We built WeGuide for the teams that have lived through that. If you've outgrown REDCap but you don't want to jump straight to an enterprise platform like Medidata or Veeva, we're probably the right next step. If you haven't outgrown REDCap yet, that's completely fine. We'll tell you honestly if staying put is the better choice.
.png)
For teams that have already hit REDCap's limits, here's what changes when you move to WeGuide.
.png)
Whitelabel participant mobile apps
.png)
Native wearable and sensor data
.png)
Continuous engagement, one time surveys
Here's the shortlist of clinical trial software most teams evaluate when they're moving on from REDCap. Each one has a different sweet spot.
WeGuide
Oracle Life Sciences
Medidata Rave
OpenClinica
Clinion
All-in-one platform
WeGuide combines eCOA, eConsent, data collection, and telehealth in a single platform with whitelabel apps under your own brand.
eConsent
.png)
Screening
Data collection
Telehealth
.png)
.png)
.png)
%20(1)%20(1)%20(1).png)
%20(1).png)
.png)
.png)
.png)
Continuous engagement, not once-off surveys
Push notifications, educational content delivery, gamification, and a study companion that guides participants through the protocol. This is the difference between collecting data when a participant remembers and collecting data on schedule because the app is genuinely useful to them. The BRACE Trial achieved 90% adherence across 6,000 participants in five countries using this architecture. See WeGuide’s patient education module →
Push notifications and reminders
.png)
Study companion
Educational content and gamification
Mobile multimodal collection
Capture the full picture of a participant's experience through forms, video, pathology, and passive sensor data all in the same app.
Forms
.png)
Video
Pathology
Sensors
.png)
%20(1).png)
.png)
%20(1).png)
.png)
%20(1).png)
.png)
.png)
Whitelabel: your study, your brand
WeGuide ships native iOS and Android apps fully branded under your organisation's name and identity. The app becomes the study's home for the participant, which is a big part of why our studies average 94% adherence.
Your brand end-to-end
.png)
App store distribution
Multilingual out of the box.
Where WeGuide goes further
For teams that need the clinical layer without the rest of the Vault platform, here's what changes when you move from Veeva Clinical to WeGuide.
Whitelabel participant mobile apps
Native wearable and sensor data
Built-in eConsent with version control
Continuous engagement, not once-off surveys
Managed cloud, not self-hosted
Multilingual studies out of the box
Integration with REDCap
Built for regulated research
Every WeGuide study runs on our managed infrastructure. Your IT team doesn't patch servers, manage backups, or run disaster recovery drills.
TGA Certified
ISO 27001
Data Hosted in Australia
GDPR Compliant
Biometric Security
256-bit AES Encryption
Faster
Your own platform ready in weeks and changes are made in minutes
Adherence Rates
High patient engagement and better quality data
Cost Saving
Reduce financial and technology risk when creating a secure health app
Patients Impacted
With our ease of use and roll out, our apps have engaged 200k+ users
Where REDCap excels
We're not going to pretend REDCap isn't a brilliant tool. It's used in tens of thousands of studies worldwide for a reason, and anyone comparing it to a commercial platform deserves an honest picture of what REDCap does well.
It's free at the licence level. For an academic team running a straightforward observational study or a one-off survey, zero licence cost is a genuine advantage. No procurement, no vendor approvals, no budget conversations.
It has a 7,000+ institution community. When your research office has already used REDCap for a decade, there's enormous institutional knowledge around it. IRB teams know the templates, biostatisticians know the data exports, research coordinators know the workflow. That familiarity has real value.
It's flexible at the form level. Drag-and-drop survey building, branching logic, calculated fields, and validation rules are all solid. For many academic studies, REDCap's form builder is all a team needs.
It has IRB-approved templates. Many institutions have pre-approved REDCap templates for common study types, which shortens ethics review time. That's a real workflow advantage that commercial platforms have to earn.
If your study fits comfortably inside those strengths, honestly, staying on REDCap is the right call. We'd rather tell you that than sell you something you don't need.
WeGuide works alongside REDCaps
You don't have to choose. Many of the research teams we work with keep REDCap for structured eCRF data capture and connect it to WeGuide for participant-facing experience, eCOA, eConsent, and wearable data. The Integration Engine supports two-way sync through the REDCap API, so teams can run hybrid architectures without rebuilding what already works.
How the switch works
For teams that are ready to move beyond REDCap or run WeGuide alongside it, here's how a typical onboarding plays out.
Discovery Call
A 30-minute conversation with one of our research delivery team. We look at your protocol, your current REDCap setup, and what's actually blocking you. No pressure, no sales pitch.
Study Configuration
Our team works alongside yours to configure the study in WeGuide. If you're keeping REDCap for eCRF data, we configure the Integration Engine at this stage. Typical timeline: two to four weeks.
Participant Onboarding
The whitelabel app goes live. Your research coordinators invite participants, who download the app under your organisation's brand. Support, push notification templates, and consent flows are all ready.
Ongoing Support
You get a named research delivery contact, not a ticketing queue. We stay involved for the life of the study.
.png)
.png)
.png)
.png)
BRACE Trial (Murdoch Children's Research Institute)
Murdoch Children's Research Institute. A global randomised controlled trial studying whether the BCG vaccine could reduce COVID-19 symptom severity. The study launched across five countries with 6,000+ participants in six weeks during the pandemic. Adherence exceeded 90%. MCRI needed engagement architecture that REDCap couldn't deliver on that timeline.
GenV (Generation Victoria)
A population health study tracking more than 100,000 Victorian families from birth. Longitudinal engagement at this scale requires push notifications, multi-modal data capture, and a whitelabel app that families will keep on their phones for years. WeGuide is the platform GenV trusted to do that.
Lendlease wellbeing programme
A patient registry for facioscapulohumeral muscular dystrophy, running longitudinally with participant-reported outcomes, wearable integration, and a patient community experience. The kind of registry REDCap could start but couldn't sustain at scale.
Questions
Straight answers on how WeGuide compares to Science 37, what migration looks like, and when staying on Science 37 is the right call.
Isn't REDCap free? Why would I pay for WeGuide?
REDCap's licence is free, but the full cost of running a REDCap study rarely is. Institutions carry the cost of server hosting, IT maintenance, security patching, disaster recovery, and developer time to build anything beyond basic forms. For studies that need mobile apps, wearables, eConsent, or engagement features, teams typically add a second or third vendor on top of REDCap. When you add it up, the total cost of ownership for a moderately complex study often matches or exceeds a WeGuide licence, which comes with managed hosting, support, and every module included.
Can I migrate data from REDCap to WeGuide?
Yes. We support data import from REDCap exports, and our Integration Engine can pull live data through the REDCap API during the migration period. Most teams don't do a hard cutover. They run the two platforms side by side until they're confident, then gradually consolidate.
Does WeGuide have an IRB-approved template library like REDCap?
Not in the same institutional sense that REDCap does, because each WeGuide study is configured for its sponsor. What we do offer is a library of validated eCOA and ePRO instruments ready to drop into a study, and we work alongside IRB teams during study setup to pre-populate approved templates. In practice, around 60% of new studies on our platform reuse a previously approved base. If your IRB has a strong preference for REDCap-based templates, that's another good reason to run both platforms in parallel through the Integration Engine.
Is WeGuide a full replacement for REDCap?
For some teams, yes. For others, no, and we'll tell you honestly which camp you're in. If your study is straightforward academic data collection through forms, with no need for mobile engagement, wearables, or eConsent, REDCap is still an excellent free option and we're genuinely happy to recommend it. WeGuide becomes the right choice when you need eCOA or ePRO instruments, a participant-facing mobile app, native wearable data, regulatory-compliant eConsent, or longitudinal engagement at scale. Many of our customers run both in parallel through our Integration Engine.
Can WeGuide integrate with our existing REDCap instance?
Yes. Our Integration Engine connects to REDCap through its API with two-way sync. If your institution has invested years in REDCap and isn't going to walk away from that data, you don't need to. You can keep REDCap for structured eCRF capture and layer WeGuide on top for participant experience, eCOA, eConsent, and wearables.
Does WeGuide support longitudinal studies the way REDCap does?
Yes, and this is actually where WeGuide tends to outperform REDCap significantly. Longitudinal studies live or die on participant retention, and our engagement architecture is built exactly for that. Automated scheduling, push notification reminders, in-app content, and the study companion experience are the reasons GenV trusted us to run a multi-year population health study across 100,000+ families.
Compare WeGuide to other clinical trial platforms
Eleven more honest platform comparisons, from academic EDC to enterprise pharma.
Veeva Vault Clinical
Life sciences cloud
Thread Research
Virtual CRO + software
Clario
eCOA specialist
Oracle Clinical
Clinical One & InForm
OpenClinica
Open-source EDC
Medable
DCT for top-50 pharma
IQVIA
Full-service CRO
Florence Healthcare
Site-side workflow
Science 37
Open-source EDC
obviohealth
Virtual site service
Medidata Rave
Enterprise pharma stack
Never miss an update
Get all the latest news, blog posts and product updates from WeGuide, delivered directly to your inbox. We'll rarely send more than one email a month.
By clicking Organise a demo, you're confirming that we can contact you to set up a demonstration.




%201.avif)





